A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 12, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

Solid Tumor

Interventions

DRUG

BL-M08D1

Administration by intravenous infusion for a cycle of 3 weeks.

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY